Abrogating the Induction of Type 2 Diabetes Mellitus Secondary to Statin Therapy

被引：0
|
作者：
Planchon, Sarah M. [1 ]
机构：
[1] Cleveland Clin, Mellen Ctr, Cleveland, OH 44195 USA
来源：
CARDIOVASCULAR DRUGS AND THERAPY | 2014年 / 28卷 / 05期
关键词：
RISK;
D O I：
10.1007/s10557-014-6551-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：393 / 394
页数：2
相关论文
共 50 条
  • [1] Lipid metabolism in type 2 diabetes mellitus and statin therapy
    Yamada, Nobuhiro
    ENDOCRINE JOURNAL, 2010, 57 : S204 - S204
  • [2] Abrogating the Induction of Type 2 Diabetes Mellitus Secondary to Statin TherapyEditorial to: “PTEN Upregulation May Explain the Development of Insulin Resistance and Type 2 Diabetes with High Dose Statins” by Y. Birnbaum et al.
    Sarah M. Planchon
    Cardiovascular Drugs and Therapy, 2014, 28 (5) : 393 - 394
  • [3] Sympathetic Transduction in Type 2 Diabetes Mellitus Impact of Statin Therapy
    Young, Benjamin E.
    Holwerda, Seth W.
    Vranish, Jennifer R.
    Keller, David M.
    Fadel, Paul J.
    HYPERTENSION, 2019, 74 (01) : 201 - 207
  • [4] Statin Efficacy in Type 1 and Type 2 Diabetes Mellitus
    Ciriacks, Kevin
    Krishnaswami, Shanthi
    Patel, Shailendra
    Kidambi, Srividya
    DIABETES, 2013, 62 : A165 - A165
  • [5] Statin therapy and related risk of new-onset type 2 diabetes mellitus
    Ruscica, Massimiliano
    Macchi, Chiara
    Morlotti, Beatrice
    Sirtori, Cesare R.
    Magni, Paolo
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (05) : 401 - 406
  • [6] The Association of Statin Therapy with Liver and Pancreatic Fat Fraction in Type 2 Diabetes Mellitus
    Parlar, Mehmet Akif
    Mutlu, Hakan
    Dogantekin, Betul
    Musaoglu, Ismail Serhat
    Albayrakoglu, Nisa Demirbosnak
    Yavuz, Mustafa Lutfi
    Ozbolat, Zehra Busra
    Kaplan, Mustafa
    DIAGNOSTICS, 2025, 15 (04)
  • [7] Risk of type 2 diabetes mellitus associated with statin therapy: evidence and possible mechanisms
    Suazo, Jose
    Rigotti, Attilio
    REVISTA MEDICA DE CHILE, 2014, 142 (02) : 222 - 228
  • [8] STATIN THERAPY FOR DYSLIPIDEMIA AND CORONARY HEART DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Cozma, M. A.
    Gaman, M. A.
    Dobrica, E. C.
    Gaman, A. M.
    Diaconu, C. C.
    JOURNAL OF HYPERTENSION, 2019, 37 : E250 - E251
  • [9] Statin and Aspirin Therapy for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus
    Udell, Jacob A.
    Scirica, Benjamin M.
    Braunwald, Eugene
    Raz, Itamar
    Steg, Ph. Gabriel
    Davidson, Jaime
    Hirshberg, Boaz
    Bhatt, Deepak L.
    CLINICAL CARDIOLOGY, 2012, 35 (12) : 722 - 729
  • [10] Effect of Statin Therapy on Diabetes Retinopathy in People With Type 2 Diabetes Mellitus: A Meta-Analysis
    Liu, Jun
    Wu, Yi-Ping
    Qi, Jun-Juan
    Yue, Zeng-Ping
    Hu, Cheng-Dong
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2021, 27
12345